Fibroblast-Derived Spondin-2: A Key Driver of Metaplasia-to-Dysplasia Progression in Gastric Epithelium
Highlight
• Fibroblast-derived Spondin-2 (SPON2) is identified as a pivotal secreted factor mediating the transition from metaplasia to dysplasia in gastric epithelial cells.
• Single-cell RNA sequencing and proteomic analyses revealed SPON2 is highly upregulated and secreted selectively by metaplasia- and cancer-derived fibroblasts compared with normal fibroblasts.
• Spatial transcriptomics localized PDGFRA/SPON2 co-expressing fibroblasts adjacent to metaplastic gastric glands in patient tissues.
• SPON2 knockdown in cancer-associated fibroblasts blocked dysplastic induction, whereas recombinant SPON2 treatment promoted dysplastic marker expression and downregulated metaplastic markers in gastroid cultures.
• Dysplastic changes induced by SPON2 were reversible upon withdrawal of SPON2 stimulation, indicating a dynamic and targetable process.
Study Background
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.